Hyper Labs, Inc

Emplifi Inc in Columbus specializes in driving enhanced customer interactions through the utilization of artificial intelligence technology. Their customer experience platform, Astute, empowers businesses to leverage AI for improved customer engagement. With a focus on harnessing the power of AI, Emplifi Inc offers innovative solutions to optimize customer experiences and drive business growth. Their commitment to leveraging technology ensures that businesses can deliver exceptional customer service and build lasting relationships. Generated from their website's infomation

Thankview is a New York-based company that specializes in harnessing the power of personalized video to engage audiences. Their suite of video features allows users to create and customize videos for various purposes, such as event invitations, gratitude messages, and marketing campaigns. With seamless integration options and a user-friendly interface, Thankview helps organizations build better relationships with their donors and achieve impressive results, including higher open rates, increased donor retention, and greater fundraising success. Through their innovative platform, Thankview enables users to collect, edit, and caption videos with ease, while also providing comprehensive metrics and smart tools for creating useful reports. Their dedicated team of video experts offers unparalleled support, ensuring a seamless and unified experience for both the creators and recipients of Thankview videos. Whether it's showcasing the impact of donor generosity or celebrating the achievements of volunteers, Thankview empowers organizations to connect with their audience on a personal level and achieve outstanding outcomes.Generated from the website

AccurKardia Inc, based in New York, NY, specializes in leveraging artificial intelligence to interpret both visible and hidden signals within electrocardiograms (ECGs), transforming them into powerful diagnostic tools and broad biomarkers that enhance patient outcomes and save lives. Their flagship application, AccurECG, has received FDA clearance and streamlines ECG interpretation, while novel applications extend the use of ECGs beyond traditional capabilities for the detection and management of various health conditions. The company also offers AKAVS and AKGuard, which are currently under development and intended solely for investigational purposes, not yet cleared or approved by the FDA for clinical use. All information provided by AccurKardia is for informational purposes only and should not be considered medical, legal, or professional advice, emphasizing the importance of consulting qualified healthcare providers for clinical decision-making. Generated from the website